AAAAAA

   
Results: 1-3 |
Results: 3
Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans
Authors: Paulussen, A Lavrijsen, K Bohets, H Hendrickx, J Verhasselt, P Luyten, W Konings, F Armstrong, M
Citation: A. Paulussen et al., Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans, PHARMACOGEN, 10(5), 2000, pp. 415-424
MEIC evaluation of acute systemic toxicity - Part VII. Prediction of humantoxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays
Authors: Clemedson, C Barile, FA Chesne, C Cottin, M Curren, R Ekwall, B Ferro, M Gomez-Lechon, MJ Imai, K Janus, J Kemp, RB Kerszman, G Kjellstrand, P Lavrijsen, K Logemann, P McFarlane-Abdulla, E Roguet, R Segner, H Thuvander, A Walum, E Ekwall, B
Citation: C. Clemedson et al., MEIC evaluation of acute systemic toxicity - Part VII. Prediction of humantoxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays, ATLA-ALT L, 28, 2000, pp. 161-200
Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions
Authors: Bohets, H Lavrijsen, K Hendrickx, J van Houdt, J van Genechten, V Verboven, P Meuldermans, W Heykants, J
Citation: H. Bohets et al., Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions, BR J PHARM, 129(8), 2000, pp. 1655-1667
Risultati: 1-3 |